These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36693543)

  • 41. Extraoral Versus Intraoral Botulinum Toxin Type A Injection for Management of Temporomandibular Joint Disc Displacement With Reduction.
    Altaweel AA; Elsayed SA; Baiomy AABA; Abdelsadek SE; Hyder AA
    J Craniofac Surg; 2019 Oct; 30(7):2149-2153. PubMed ID: 31232992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in levels of cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial.
    Waluyo Y; Budu ; Bukhari A; Adnan E; Haryadi RD; Idris I; Hamid F; Usman A; Johan MP; Zainuddin AA
    J Rehabil Med; 2021 May; 53(5):jrm00196. PubMed ID: 33904585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of intra-articular hypertonic dextrose prolotherapy versus normal saline for knee osteoarthritis: a protocol for a triple-blinded randomized controlled trial.
    Sit RWS; Wu RWK; Reeves KD; Rabago D; Chan DCC; Yip BHK; Chung VCH; Wong SYS
    BMC Complement Altern Med; 2018 May; 18(1):157. PubMed ID: 29764447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolotherapy (proliferation therapy) in the treatment of TMD.
    Hakala RV
    Cranio; 2005 Oct; 23(4):283-8. PubMed ID: 16353469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is dextrose prolotherapy beneficial in the management of temporomandibular joint internal derangement? A systematic review.
    Bahgat MM; Abdel-Hamid AM
    Cranio; 2023 Apr; ():1-9. PubMed ID: 37097125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient experience and satisfaction with different temporomandibular joint treatments: A retrospective study.
    Rodrigues ALP; Cardoso HJ; Ângelo DF
    J Craniomaxillofac Surg; 2023 Jan; 51(1):44-51. PubMed ID: 36739190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?
    Martenot A; Devoti JF; Pons M; Meyer C; Brumpt E; Louvrier A; Bertin E
    J Stomatol Oral Maxillofac Surg; 2023 Nov; 125(5):101715. PubMed ID: 38013116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
    Villa S; Raoul G; Machuron F; Ferri J; Nicot R
    J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors for patient satisfaction of a single intra-articular injection of crosslinked hyaluronic acid combined with mannitol (HANOX-M-XL) in patients with temporomandibular joint osteoarthritis. Results of a prospective open-label pilot study (HAPPYMINI-ARTEMIS trial).
    Baron D; Baron H; Baerer C; Bodere C; Conrozier T
    BMC Musculoskelet Disord; 2022 Apr; 23(1):392. PubMed ID: 35477406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.
    Yoshida K
    Toxins (Basel); 2018 Apr; 10(5):. PubMed ID: 29693593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporomandibular Disorder Patients Benefit From Intramuscular Botulinum Toxin Type a Injections.
    Oksanen E; Männistö V; Kormi E; Vallioniemi H; Suojanen J
    J Craniofac Surg; 2022 Jun; 33(4):1159-1161. PubMed ID: 34743162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain.
    Kim WM; Lee HG; Jeong CW; Kim CM; Yoon MH
    J Altern Complement Med; 2010 Dec; 16(12):1285-90. PubMed ID: 21138388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations.
    Reeves KD; Sit RW; Rabago DP
    Phys Med Rehabil Clin N Am; 2016 Nov; 27(4):783-823. PubMed ID: 27788902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.
    Ataran R; Bahramian A; Jamali Z; Pishahang V; Sadeghi Barzegani H; Sarbakhsh P; Yazdani J
    J Dent (Shiraz); 2017 Sep; 18(3):157-164. PubMed ID: 29034269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of prolotherapy in temporomandibular joint disorder: a quality of life assessment.
    Dasukil S; Arora G; Shetty S; Degala S
    Br J Oral Maxillofac Surg; 2021 Jun; 59(5):599-604. PubMed ID: 33750579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: randomized clinical trial.
    Rezasoltani Z; Azizi S; Najafi S; Sanati E; Dadarkhah A; Abdorrazaghi F
    Int J Rehabil Res; 2020 Sep; 43(3):219-227. PubMed ID: 32776763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of severe temporomandibular joint clicking with botulinum toxin in the lateral pterygoid muscle in two cases of anterior disc displacement.
    Bakke M; Møller E; Werdelin LM; Dalager T; Kitai N; Kreiborg S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Dec; 100(6):693-700. PubMed ID: 16301150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: results of a single-arm uncontrolled study with 1-year follow-up.
    Rabago D; Zgierska A; Fortney L; Kijowski R; Mundt M; Ryan M; Grettie J; Patterson JJ
    J Altern Complement Med; 2012 Apr; 18(4):408-14. PubMed ID: 22515800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.